ZIGAKIBART
UNII WM18Z62RTI

Substance Identification & Data

This profile provides standardized clinical and technical data for Zigakibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WM18Z62RTI.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2642175-46-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

WM18Z62RTI

CAS Registry Number

2642175-46-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZIGAKIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C142822

National Cancer Institute reference terminology for clinical and research data.

INN ID

12304

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-201

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zigakibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZIGAKIBART

Common Names & Synonyms

ANTI-A PROLIFERATION-INDUCING LIGAND MONOCLONAL ANTIBODY BION-1301

ANTI-APRIL MONOCLONAL ANTIBODY BION-1301

ANTI-TNFSF13 MONOCLONAL ANTIBODY BION-1301

BION 1301 [WHO-DD]

IMMUNOGLOBULIN G4 (229-PROLINE), ANTI-(HUMAN PROLIFERATION-INDUCING LIGAND PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL BION-1301 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BION-1301 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS TNFSF13 (TUMOR NECROSIS FACTOR (TNF) SUPERFAMILY MEMBER 13, APRIL, CD256)), HUMANIZED MONOCLONAL ANTIBODY

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS TNFSF13 (TUMOR NECROSIS FACTOR (TNF) SUPERFAMILY MEMBER 13, APRIL, CD256)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN HUMANIZED (1-448) (VH HUMANIZED (HOMO SAPIENS IGHV1-3*01 (83,7%) -(IGHD) -IGHJ4*01 (84,6%), CDR-IMGT (8.8.14) (26-33.51-58.97-110)) (1-121)- HOMO SAPIENS IGHG4*01, G4V5 H P10, NG4M(A) CH2 L92 (CH1 (122-219), HINGE 1-12 S10>P (229) (220-231), CH2 L92 (310) (232-341), CH3 (342-446), CHS (447-448)) (122- 448)), (135-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') (V-KAPPA HOMO SAPIENS IGKV1-5*01 (84%) -IGKJ2*02 (100%), CDR-IMGT (6.3.9) (27-32.50- 52.89-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')); DIMER (227-227'':230- 230'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, GLYCOFORM ALFA

ZIGAKIBART [INN]

ZIGAKIBART [USAN]

ZIGAKIBART [WHO-DD]